Cargando…
Abelmoschus manihot – a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial
BACKGROUND: IgA nephropathy (IgAN) is one of the most common primary glomerular diseases worldwide, but effective therapy remains limited and many patients progress to end-stage renal disease (ESRD). Only angiotensin-converting enzyme inhibitors (ACE-I)/angiotensin-receptor blockers (ARB) show a hig...
Autores principales: | Li, Ping, Chen, Yi-zhi, Lin, Hong-li, Ni, Zhao-hui, Zhan, Yong-li, Wang, Rong, Yang, Hong-tao, Fang, Jing-ai, Wang, Nian-song, Li, Wen-ge, Sun, Xue-feng, Chen, Xiang-mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387231/ https://www.ncbi.nlm.nih.gov/pubmed/28395659 http://dx.doi.org/10.1186/s13063-016-1774-6 |
Ejemplares similares
-
The Effectiveness and Safety of Abelmoschus manihot in Treating IgA Nephropathy: A Systematic Review and Meta-Analysis
por: Jia, Qi, et al.
Publicado: (2022) -
Abelmoschus manihot for Diabetic Nephropathy: A Systematic Review and Meta-Analysis
por: Shi, Liwei, et al.
Publicado: (2019) -
The pharmacological mechanism of Abelmoschus manihot in the treatment of chronic kidney disease
por: Wei, Cuiting, et al.
Publicado: (2023) -
Supplementation of Abelmoschus manihot Ameliorates Diabetic Nephropathy and Hepatic Steatosis by Activating Autophagy in Mice
por: Kim, Hwajin, et al.
Publicado: (2018) -
Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis
por: Xu, Zhongchi, et al.
Publicado: (2022)